Lorazepam
- Product NDC
- 70518-3225
- 11-digit product format
- 705183225
- Labeler code
- 70518
- Product ID
- 70518-3225_e8cabcc7-74c7-150a-e053-2a95a90acfeb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA076150
- Marketing category
- ANDA
- Marketing start
- 2021-09-17
- Marketing end
- 0000-00-00
- Substance
- LORAZEPAM
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3225-0 | 70518322500 | 10 VIAL in 1 CARTON (70518-3225-0) > 10 mL in 1 VIAL | 10 vial | 2021-09-17 | 0000-00-00 | No | No | Current |
| 70518-3225-1 | 70518322501 | 10 mL in 1 VIAL (70518-3225-1) | 10 ml | 2022-09-15 | 0000-00-00 | No | No | Current |